May 15, 2017 / 11:49 AM / 3 months ago

BRIEF-Moleculin Biotech Qtrly net loss per share $0.02

May 15 (Reuters) - Moleculin Biotech Inc:

* Moleculin Biotech, Inc. Reports financial results for the first quarter ended march 31, 2017

* As of March 31, 2017, company had $8.88 million of cash and cash equivalents compared to $5.00 million at december 31, 2016

* Qtrly net loss per share $0.02

* Company believes it will be able to publicly announce results from its phase i/ii clinical trial sometime in 2018 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below